You are here:

Risperidone orodispersible tablets (Risperdal Quicklet®)

Advice

Recommended for restricted use within NHS Scotland.

RECOMMENDATION.

Risperdal Quicklet, for the treatment of acute and chronic schizophrenia and other similar psychotic conditions, should be reserved for those patients in whom rapid oral absorption is indicated.

Drug Details

Drug Name: Risperidone orodispersible tablets (Risperdal Quicklet®)
SMC Drug ID: 41/03
Manufacturer: Janssen-Cilag Ltd
Indication: Acute and chronic schizophrenic psychoses
BNF Category:
Sub Category: 4.2 Drugs used in psychoses and related disorders
Submission Type: Full submission
Status: Restricted
Date Advice Published: 9 May 2003

Back